lanreotide

Ligand id: 2031

Name: lanreotide

Structure and Physico-chemical Properties

2D Structure
Classification
Compound class Peptide or derivative
Approved drug? Yes (UK (2001), FDA (2007))
IUPAC Name
10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[(2-amino-3-naphthalen-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
International Nonproprietary Names
INN number INN
6649 lanreotide
Synonyms
BIM 23014 | DC 13-116 | lanreotide acetate | Somatuline®
Database Links
CAS Registry No. 108736-35-2
GtoPdb PubChem SID 135652022
PubChem CID 71349
Search Google for chemical match using the InChIKey PUDHBTGHUJUUFI-UHFFFAOYSA-N
Search Google for chemicals with the same backbone PUDHBTGHUJUUFI
Search PubMed clinical trials lanreotide
Search PubMed titles lanreotide
Search PubMed titles/abstracts lanreotide
Search UniChem for chemical match using the InChIKey PUDHBTGHUJUUFI-UHFFFAOYSA-N
Search UniChem for chemicals with the same backbone PUDHBTGHUJUUFI
Wikipedia Lanreotide
Comments
Lanreotide is a synthetic analogue of somatostatin. The compound is represented by a PubChem entry (linked to above) without specified stereochemistry, while ChEMBL represents lantreotide with the entry CHEMBL1201185.